Page Nct des essais cliniques
Clinical Trial Results:
Efectos del Arzoxifeno en la incidencia de fracturas vertebrales y en la incidencia de cáncer de mama invasivo en las mujeres posmenopáusicas con osteoporosis o con baja densidad ósea Effects of Arzoxifene on Vertebral Fracture Incidence and on Invasive Breast Cancer Incidence in Postmenopausal Women with Osteoporosis or with Low Bone Density
| Summary | |
EudraCT number | 2004-001562-41 |
Trial protocol | ES |
Global completion date | 30 Nov 2009 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 20 Jan 2018 |
First version publication date | 20 Jan 2018 |
Other versions | |
Summary report(s) | GJAD Approved CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.